(32) found that AD-MSC-EVs inhibited p62/LC3 and mTOR signaling pathways, increased the levels of autophagy-related proteins, and ameliorated cell damage of podocyte by inhibiting the signaling pathway of miR-486/Smad1/mTOR. Here, SMAD1 is linked to Alzheimer disease.